RECTACORT HC- hydrocortisone acetate suppository

Country: Amerika Syarikat

Bahasa: Inggeris

Sumber: NLM (National Library of Medicine)

Bahan aktif:

HYDROCORTISONE ACETATE (UNII: 3X7931PO74) (HYDROCORTISONE - UNII:WI4X0X7BPJ)

Boleh didapati daripada:

REMEDYREPACK INC.

INN (Nama Antarabangsa):

HYDROCORTISONE ACETATE

Komposisi:

HYDROCORTISONE ACETATE 25 mg

Jenis preskripsi:

PRESCRIPTION DRUG

Status kebenaran:

unapproved drug other

Ciri produk

RECTACORT - HC- HYDROCORTISONE ACETATE SUPPOSITORY
REMEDYREPACK INC.
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
DESCRIPTION:
HYDROCORTISONE ACETATE, 25 mg
Rectal Suppositories
DESCRIPTION: Hydrocortisone Acetate is a corticosteroid designated
chemically as pregn-4-ene-3,
20-dione, 21-(acetyloxy)-11, 17-dihydroxy-(11β) with the following
structural formula:
Each rectal suppository contains hydrocortisone acetate, USP 25 mg in
a specially blended
hydrogenated vegetable oil base.
CLINICAL PHARMACOLOGY:
In normal subjects, about 26% of hydrocortisone acetate is absorbed
when the suppository is applied to
the rectum. Absorption of hydrocortisone acetate may vary across
abraded or inflamed surfaces.
Topical steroids are primarily effective because of their
anti-inflammatory, anti-pruritic and
vasconstrictive action.
INDICATIONS AND USAGE:
Hydrocortisone acetate suppositories are indicated for the use in
inflamed hemorrhoids, post-
irradiation (factitial) proctitis; as an adjunct in the treatment of
chronic ulcerative colitis; cryptitis; and
other inflammatory conditions of anorectum and puritus ani.
CONTRAINDICATIONS:
Hydrocortisone acetate suppositories are indicated for use in inflamed
hemorrhoids, post-irradiation
(factitial) proctitis; as an adjunct in the treatment of chronic
ulcerative colitis; cryptitis; and other
inflammatory conditions of anorectum and pruritus ani.
PRECAUTIONS:
Do not use hydrocortisone acetate suppositories unless a adequate
proctologic examination is made.
If irritation develops, the product should be discontinued and
appropriate therapy instituted.
In the presence of an infection, the use of an appropriate antifungal
or antibacterial agent should be
instituted. If a favorable response does not occur promptly,
hydrocortisone acetate should be
discontinued until the infection has been adequately controlled.
Carcinogenesis: No long term stu